Compare Stocks: TXG, PACB, TWST, and MTD

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
MTD Mettler-Toledo International	$1,680.77 +0.4%	$1,494.69	$1,023.05 ▼ $1,728.66	$33.68B	1.16	182,984 shs	212,589 shs
PACB Pacific Biosciences of California	$2.35 -10.0%	$1.83	$1.07 ▼ $3.43	$730.45M	2.21	8.24 million shs	9.09 million shs
TWST Twist Bioscience	$129.04 -15.5%	$153.11	$23.30 ▼ $219.71	$8.09B	2.19	1.76 million shs	2.67 million shs
TXG 10x Genomics	$61.63 -12.1%	$74.17	$12.80 ▼ $102.81	$8.03B	2.03	3.02 million shs	5.17 million shs

7 Blue-Chip Stocks to Add To Your Forever Portfolio

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
MTD Mettler-Toledo International	0.00%	+0.44%	+12.65%	+15.84%	+18.19%
PACB Pacific Biosciences of California	0.00%	+23.70%	+2.76%	+83.80%	+11.54%
TWST Twist Bioscience	0.00%	+9.19%	-19.02%	+51.18%	+364.52%
TXG 10x Genomics	0.00%	-2.01%	-25.02%	+49.14%	+414.00%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
MTD Mettler-Toledo International	$1,680.77 +0.4%	$1,494.69	$1,023.05 ▼ $1,728.66	$33.68B	1.16	182,984 shs	212,589 shs
PACB Pacific Biosciences of California	$2.35 -10.0%	$1.83	$1.07 ▼ $3.43	$730.45M	2.21	8.24 million shs	9.09 million shs
TWST Twist Bioscience	$129.04 -15.5%	$153.11	$23.30 ▼ $219.71	$8.09B	2.19	1.76 million shs	2.67 million shs
TXG 10x Genomics	$61.63 -12.1%	$74.17	$12.80 ▼ $102.81	$8.03B	2.03	3.02 million shs	5.17 million shs

7 Blue-Chip Stocks to Add To Your Forever Portfolio

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
MTD Mettler-Toledo International	0.00%	+0.44%	+12.65%	+15.84%	+18.19%
PACB Pacific Biosciences of California	0.00%	+23.70%	+2.76%	+83.80%	+11.54%
TWST Twist Bioscience	0.00%	+9.19%	-19.02%	+51.18%	+364.52%
TXG 10x Genomics	0.00%	-2.01%	-25.02%	+49.14%	+414.00%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
MTD Mettler-Toledo International	2.33	Hold	$1,469.15	-12.59% Downside
PACB Pacific Biosciences of California	1.83	Reduce	$1.71	-27.13% Downside
TWST Twist Bioscience	2.46	Hold	$143.67	11.33% Upside
TXG 10x Genomics	2.22	Hold	$68.00	10.34% Upside

Current Analyst Ratings Breakdown

Latest TXG, PACB, TWST, and MTD Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/23/2026	TXG 10x Genomics	Stephens Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Overweight ➝ Equal Weight
10/19/2026	MTD Mettler-Toledo International	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold (C+) ➝ Buy (B-)
10/13/2026	PACB Pacific Biosciences of California	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)
10/13/2026	TXG 10x Genomics	Stifel Nicolaus Subscribe to MarketBeat All Access to unlock brokerage rankings	Set Price Target		$70.00
10/13/2026	TXG 10x Genomics	TD Cowen Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Hold	$47.00 ➝ $70.00
10/13/2026	TWST Twist Bioscience	TD Cowen Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$115.00 ➝ $190.00
10/13/2026	MTD Mettler-Toledo International	Morgan Stanley Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Equal Weight	$1,450.00 ➝ $1,575.00
10/12/2026	TXG 10x Genomics	Morgan Stanley Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Equal Weight	$40.00 ➝ $70.00
10/12/2026	TXG 10x Genomics	Canaccord Genuity Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$60.00 ➝ $100.00
10/12/2026	TWST Twist Bioscience	Canaccord Genuity Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$120.00 ➝ $205.00
10/8/2026	TWST Twist Bioscience	Jefferies Financial Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Hold	$150.00

(Data available from 11/2/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
MTD Mettler-Toledo International	$4.03B	8.37	$49.82 per share	33.74	($1.16) per share	-1,448.94
PACB Pacific Biosciences of California	$160.01M	4.57	$0.71 per share	3.30	$0.02 per share	117.50
TWST Twist Bioscience	$431.80M	18.74	N/A	N/A	$7.84 per share	16.46
TXG 10x Genomics	$642.82M	12.49	N/A	N/A	$6.24 per share	9.88

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
MTD Mettler-Toledo International	$869.19M	$44.43	37.83	32.09	3.37	21.91%	-1,212.14%	25.11%	11/5/2026 (Estimated)
PACB Pacific Biosciences of California	-$546.38M	-$0.43	N/A	N/A	N/A	-82.49%	-5,752.12%	-19.52%	11/3/2026 (Estimated)
TWST Twist Bioscience	-$77.67M	-$2.22	N/A	N/A	N/A	-31.66%	-28.64%	-19.94%	11/12/2026 (Estimated)
TXG 10x Genomics	-$43.54M	-$0.59	N/A	N/A	N/A	-12.18%	-9.33%	-7.30%	11/5/2026 (Estimated)

Latest TXG, PACB, TWST, and MTD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/12/2026	Q4 2026	TWST Twist Bioscience	-$0.3845	N/A	N/A	N/A	$123.59 million	N/A
11/5/2026	Q3 2026	MTD Mettler-Toledo International	$12.12	N/A	N/A	N/A	$1.07 billion	N/A
11/5/2026	Q3 2026	TXG 10x Genomics	-$0.2670	N/A	N/A	N/A	$147.96 million	N/A
11/3/2026	Q3 2026	PACB Pacific Biosciences of California	-$0.1260	N/A	N/A	N/A	$43.82 million	N/A
8/6/2026	Q2 2026	TXG 10x Genomics	-$0.2431	-$0.14	+$0.1031	-$0.14	$146.67 million	$151.04 million
8/3/2026	Q2 2026	PACB Pacific Biosciences of California	-$0.1280	-$0.14	-$0.0120	-$0.14	$42.90 million	$39.01 million
8/3/2026	Q3 2026	TWST Twist Bioscience	-$0.5063	-$0.56	-$0.0538	-$0.56	$114.55 million	$118.38 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
MTD Mettler-Toledo International	N/A	N/A	N/A	N/A	N/A
PACB Pacific Biosciences of California	N/A	N/A	N/A	N/A	N/A
TWST Twist Bioscience	N/A	N/A	N/A	N/A	N/A
TXG 10x Genomics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
MTD Mettler-Toledo International	159.45	1.12	0.78
PACB Pacific Biosciences of California	N/A	4.92	4.03
TWST Twist Bioscience	0.03	2.67	2.38
TXG 10x Genomics	N/A	5.69	5.25

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
MTD Mettler-Toledo International	95.07%
PACB Pacific Biosciences of California	N/A
TWST Twist Bioscience	N/A
TXG 10x Genomics	84.68%

Insider Ownership

Company	Insider Ownership
MTD Mettler-Toledo International	0.71%
PACB Pacific Biosciences of California	3.70%
TWST Twist Bioscience	3.08%
TXG 10x Genomics	8.84%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
MTD Mettler-Toledo International	18,100	20.04 million	19.90 million	Optionable
PACB Pacific Biosciences of California	485	310.83 million	299.33 million	Optionable
TWST Twist Bioscience	979	62.71 million	60.78 million	Optionable
TXG 10x Genomics	1,178	130.29 million	118.77 million	Optionable

TXG, PACB, TWST, and MTD Headlines

Recent News About These Companies

10x Genomics Appoints Two New Directors to Board

1 hour ago | tipranks.com

10x Genomics Sinks 12%, Twist Down 15%, PacBio Down 10% as Genomics Stocks Give Back Rebound

2 hours ago | finance.yahoo.com

10x Genomics (NASDAQ:TXG) Stock Price Down 6.5% - Here's What Happened

4 hours ago | marketbeat.com

10x Genomics Launches Sentira Single Cell, A New Agentic AI Experience for Chromium Analysis

November 2 at 9:00 AM | prnewswire.com

10x Genomics $TXG Stock Sold by Sumitomo Mitsui Trust Group Inc.

November 2 at 7:41 AM | marketbeat.com

Will TXG Stock Ever Get Back To Its Old High?

October 30 at 4:27 PM | finance.yahoo.com

10x Genomics (NASDAQ:TXG) Shares Gap Down - Here's Why

October 30 at 11:59 AM | marketbeat.com

3 Promising Genomics Stocks to Add to Your Portfolio Now

October 30 at 11:11 AM | zacks.com

10x Genomics $TXG Stock: Simplify Asset Management Inc. Lowers Stake

October 29, 2026 | marketbeat.com

10x Genomics (TXG) Expected to Announce Earnings on Thursday

October 29, 2026 | marketbeat.com

10x Genomics: Atera Takes Off, But Valuation Flies Too High

October 28, 2026 | seekingalpha.com

10x Genomics (NASDAQ:TXG) Shares Climb 8% - Here's What Happened

October 28, 2026 | marketbeat.com

10x Genomics (TXG) Stock Looks Expensive On Its 485% One Year Run

October 28, 2026 | finance.yahoo.com

10x Genomics (NASDAQ:TXG) Shares Cross Above Fifty Day Moving Average Following Analyst Downgrade

October 28, 2026 | americanbankingnews.com

10x Genomics to Participate in the 2026 Jefferies Global Healthcare Conference

October 27, 2026 | prnewswire.com

44,600 10x Genomics $TXG Shares Bought by Maxi Investments CY Ltd

October 27, 2026 | marketbeat.com

10x Genomics (NASDAQ:TXG) Stock Price Breaks Above Fifty Day Moving Average on Analyst Downgrade

October 26, 2026 | marketbeat.com

10x Genomics (NASDAQ:TXG) Rating Lowered to Equal Weight at Stephens

October 25, 2026 | americanbankingnews.com

1 unprofitable stock with exciting potential and 2 that underwhelm

October 23, 2026 | finance.yahoo.com

10x Genomics (NASDAQ:TXG) Given Equal Weight Rating at Stephens

October 23, 2026 | marketbeat.com

10x Genomics consensus price target increased by 42.11% to MX$1,361.84

October 22, 2026 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

TXG, PACB, TWST, and MTD Company Descriptions

Mettler-Toledo International NYSE:MTD

$1,680.77 +5.96 (+0.36%)

Closing price 03:59 PM Eastern

Extended Trading

$1,673.20 -7.57 (-0.45%)

As of 06:12 PM Eastern

Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments. Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems. The company's retail weighing solutions consist of weighing and software solutions, AI-driven image recognition solution, and automated packaging and labelling solutions for the meat backroom. It serves the life science industry, independent research organizations, and testing labs; food and beverage manufacturers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was incorporated in 1991 and is based in Columbus, Ohio.

Pacific Biosciences of California NASDAQ:PACB

$2.35 -0.26 (-9.96%)

Closing price 04:00 PM Eastern

Extended Trading

$2.38 +0.02 (+1.06%)

As of 06:26 PM Eastern

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

Twist Bioscience NASDAQ:TWST

$129.04 -23.74 (-15.54%)

Closing price 04:00 PM Eastern

Extended Trading

$128.84 -0.20 (-0.16%)

As of 06:23 PM Eastern

Twist Bioscience Corporation engages in the manufacture and sale of synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels, primarily used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, the company provides synthetic SARS-CoV-2 RNA reference sequences as positive controls for the development of both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries used for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

10x Genomics NASDAQ:TXG

$61.63 -8.48 (-12.10%)

Closing price 04:00 PM Eastern

Extended Trading

$61.53 -0.10 (-0.16%)

As of 06:29 PM Eastern

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest TXG, PACB, TWST, and MTD Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest TXG, PACB, TWST, and MTD Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

TXG, PACB, TWST, and MTD Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

TXG, PACB, TWST, and MTD Company Descriptions

Mettler-Toledo International NYSE:MTD

Pacific Biosciences of California NASDAQ:PACB

Twist Bioscience NASDAQ:TWST

10x Genomics NASDAQ:TXG

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest TXG, PACB, TWST, and MTD Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest TXG, PACB, TWST, and MTD Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

TXG, PACB, TWST, and MTD Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

TXG, PACB, TWST, and MTD Company Descriptions

Mettler-Toledo International NYSE:MTD

Pacific Biosciences of California NASDAQ:PACB

Twist Bioscience NASDAQ:TWST

10x Genomics NASDAQ:TXG

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools